PKC Isotype that Affects the Interaction of HRF with Na, K-ATPase

Na,K-ATPase와 IgE-Dependent Histamine Releasing Factor의 결합에 영향을 미치는 Protein Kinase C Isotype에 관한 연구

  • 손원주 (이화여자대학교 약학대학) ;
  • 이경림 (이화여자대학교 약학대학)
  • Published : 2005.12.01

Abstract

IgE-dependent histamine releasing factor (HRF), previously known as P23/P21 or translationally controlled tumor protein (TCTP), induces the degranulation of histamine in mast cell and basophil. Yeast two hybrid results showed that HRF interacts with the alpha subunit of Na, K-ATPase, suggesting that HRF is a regulator for governing the activity of Na, K-ATPase. In this study, we examined the interaction of HRF and Wa,K-ATPase after treatments of various PKC isotype inhibitors. Membrane fractionation, pull-down assay and immunoprecipitation results showed that PKC $\alpha,\;PKC\;\beta,\;\delta$ subunits are involved in the phosphorylation of HRF. However, these results did not correlate with the results of histamine release assay since histamine release assay results suggested that some PKC isotype inhibitors induced the histamine release in RBL-2H3 cell.

본 실험에서는 MRF가 다량 존재하는 RBL-2H3 세포주에 다양한 PKC isotype별 억제제를 처리하여 in vitro상에서 Na, K-ATPase $\alpha$1L3를 이용한 pull-down assay와 RBL-2H3 세포를 이용한 membrane fractionation을 실시하였다. 그 결과 HRF는 in vitro에서 $\alpha$1L3와 결합한다는 사실을 재확인 할 수 있었고 실제 세포주 내에서 Na,K-ATPase와 결합한다는 것을 알 수 있었다. 사용한 약물로부터 PKC $\alpha,\;\beta,\;\delta$뿐 아니라 protein phosphatase 2B(PP2B)도 HRF와 $\alpha$1L3의 결합에 관여한다는 사실을 알 수 있었다. 또한 이들 PKC, PP2B에 의해 인산화된 HRF 분자는 cytosolic fraction으로 이행할 수 있으며 이러한 결과는 탈인산화된 HRF가 Na,K-ATPase와 결합하여 Na, K-ATPase의 기능을 조절한다고 추정할 수 있다. 그러나 약물자체가 histamine 분비에 영향을 미칠 수 있으며 cytosolic HRF보다 exocytosis된 HRF가 histamine를 더 분비하도록 할 수 있으므로, 약물을 전처리한 세포에 외부에서 HRF를 첨가하여 histamine이 유리되는 정도가 어떻게 변화하는지를 HRF를 가하지 않은 결과와 비교해야 할 것이다.

Keywords

References

  1. Atkins, F., E. Middleton, D. Triggle, and G. Drzewiecki. 1981. Effects of calcium antagonists on human basophil histamine release. J. Allergy Clin. Immunol. 68: 28
  2. Beaven, M. A., and R. A. Baumgartner. 1996. Downstream signals initiated in mast cells by Fcepsilon RI and other receptors. Curr. Opin. Immunol. 8: 766-772 https://doi.org/10.1016/S0952-7915(96)80002-1
  3. Bheekha-Escura, R., S. R. Chance, J. M. Langdon, D. W. Jr. MacGlashan, and S. M. MacDonald. 1999. Pharmacologic regulation of histamine release by the human recombinant histamine releasing factor. J. Allergy Clin. Immunol. 103: 937-943 https://doi.org/10.1016/S0091-6749(99)70442-2
  4. Chitpatima, S. T., S. Makrides, R. Bandyopadhyay, and G. Brawerman. 1988. Nucleotide sequence of a major messenger RNA for a 21 kilodalton polypeptide that is under translational control in mouse tumor cells. Nucl. Acid Res. 16: 2350 https://doi.org/10.1093/nar/16.5.2350
  5. Gentile, D. A. and D. P. Skoner. 1996. A role for the sodium, potassium adenosine triphosphatase (Na,K-ATPase) enzyme in degranulation of rat basophilic leukemia cells. Clin. Exp. Allergy 26: 1449-1460 https://doi.org/10.1111/j.1365-2222.1996.tb00547.x
  6. Hughes, G. J., S. Frutiger, N. Paquet, C. Pasquali, J. C. Sanchez, and A. Bairoch. 1993. Human liver protein map: a protein identified in several nontumoral cells including erythrocytes. Electrophoresis 18: 150-155 https://doi.org/10.1002/elps.1150180127
  7. Hultsch, T., P. Brand, S. Lohmann, J. Saloga, R. L. Kincaid., and J. Knop. 1998. Direct evidence that FK506 inhibition of Fcepsilon RI-mediated exocytosis from RBL mast cells involves calcineurin. Arch Dermatol. Res. 290: 258-263 https://doi.org/10.1007/s004030050301
  8. Ludowyke, R. J. K. Kawasugi, and P. W. French. 1994. PMA and calcium ionophore induce myosin and F-actin rearrangement during histamine recretion from RBL-2H3 cells. Cell Motil. Cytoskeleton 29: 354-365 https://doi.org/10.1002/cm.970290408
  9. MacDonald, S. M. 1997. Human recombinant histamine releasing factor. Int. Arch. Allergy Immunol. 113: 187-189 https://doi.org/10.1159/000237542
  10. MacDonald, S. M., L. M. Lichtenstein, D. Proud, M. Plaut, R. M. Naclerio, D. W. MacGlasham, and A. Kagey- Sobotka. 1987. Studies of IgE-dependent histamine releasing factors: heterogenecity of IgE. J. Immunol. 139: 506-512
  11. MacDonald, S. M., T. Rafuar, J. Langdon, and L. M. Lichtenstein. 1995. Molecular identification of an. IgE-dependent histamine releasing factor. Science 269: 688-690 https://doi.org/10.1126/science.7542803
  12. MacGlashan, D. Jr., K. Miura, and S. Lavens-Phillips. 2000. Pharmacology of IgE-mediated desensitization of human basophils : Effects of protein kinase C and Src-family kinase inhibitors. Biochem Pharmacol. 60: 1717-1727 https://doi.org/10.1016/S0006-2952(00)00490-1
  13. Miadonna, A., A. Tedeschi. and E. Leggiere. 1987. Effects of nifedipine on histamine release from human basophil leucocytes. Allergy 42: 298-304 https://doi.org/10.1111/j.1398-9995.1987.tb02213.x
  14. Sampson, H. A., K. R. Broadbent, and J. Bernhisel-Broadbent. 1989. Spontaneous release of histamine from basophils and histamine releasing factor in patients with atopic dermatitis and food hypersensitivity. N. Engl. J. Med. 321: 228-232 https://doi.org/10.1056/NEJM198907273210405
  15. Sierchio, J., D. Ritchie, C. Bisshop, and R. Lapetola. 1983. Calcium channel blockers in immediate hypersensitivity. Pharmacologist 25: 120
  16. Smith, T. F., F. Sanchez-Legrand, and L. P. Mckean. 1992. Role of sodium in mediator release from human basophils. J. Allergy Clin. Tmmunol. 89: 978-986 https://doi.org/10.1016/0091-6749(92)90220-V
  17. Wantke, F., D. W. MacGlashan, J. M. Langdon, and S. M. MacDonald. 1999. The hyman recombinant histamine releasing factor: functional evidence that it does not bind to the IgE molecule. J. Allergy Clin. Immunol. 103: 642-648 https://doi.org/10.1016/S0091-6749(99)70237-X
  18. Yoon, T., J. Jung, M. Kim, K. M. Lee, E. C. Choi, and K. Lee. 2000. Identification of the self-interaction of rat TCTPI IgE-dependent histamine-releasing factor using yeast twohybrid system. Arch. Biochem. Biophys. 384: 379-382 https://doi.org/10.1006/abbi.2000.2108